Pyra Pharmaceutical Limited - Company Profile

It is a pharma public limited company based in Kolkata, West Bengal, India, established in 2011.
2011 Kolkata, West Bengal, India Active
Last Updated:
Access Report
About Pyra Pharmaceutical Limited

Pyra Pharmaceutical Limited, a active public limited company, was established on 23 July 2011 in Kolkata, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24232WB2011PLC165248. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Subir Choudhury (Director), Ayush Poddar (Director), Sailesh Sahal (Director). Past directors included Sailesh Sahal, Devashish Poddar. Its latest AGM occurred on 13 September 2025, with the balance sheet filed on 31 March 2025. It is based at 18, Rabindra Sarani Poddar Court, Gate No 1, 9Th Floor, Kolkata, West Bengal, 700001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232WB2011PLC165248

  • Registration Number

    165248

  • Incorporation Date

    23 July 2011

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 14 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Pyra Pharmaceutical Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Pyra Pharmaceutical Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Pyra Pharmaceutical Limited?
Current Directors
Name Designation Appointment Date Status
Subir Choudhury Director 23 Jul 2011 Current
Ayush Poddar Director 23 Jul 2011 Current
Sailesh Sahal Director 13 Aug 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Director 14 Aug 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Pyra Pharmaceutical.

Pyra Pharmaceutical Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Pyra Pharmaceutical revenue growth over time
Pyra Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Pyra Pharmaceutical?

In 2017, Pyra Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Pyra Pharmaceutical?

Unlock and access historical data on people associated with Pyra Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pyra Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pyra Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Pyra Pharmaceutical
Recent Activity within the Organization
  • Annual General Meeting

    The activity Pyra Pharmaceutical Limited last Annual general meeting of members was held on 13 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Pyra Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata. was completed.

  • Director Appointment

    Sailesh Sahal was appointed as a Director was appointed as a Director on 13 Aug 2018 & has been associated with this company since 7 years 5 months . was recorded as a recent event.

  • Director Appointment

    Progress on Subir Choudhury was appointed as a Director was appointed as a Director on 23 Jul 2011 & has been associated with this company since 14 years 6 months . was documented.

  • Director Appointment

    The activity Ayush Poddar was appointed as a Director was appointed as a Director on 23 Jul 2011 & has been associated with this company since 14 years 6 months . was completed.

  • Company Incorporation

    Progress on Pyra Pharmaceutical Limited was registered on 23 Jul 2011 with Roc Kolkata & aged 14 years 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Pyra Pharmaceutical Limited?

The CIN of Pyra Pharmaceutical Limited is U24232WB2011PLC165248.

Where is Pyra Pharmaceutical Limited headquartered?

Pyra Pharmaceutical Limited is headquartered at 18, Rabindra Sarani Poddar Court, Gate No 1, 9Th Floor, Kolkata, West Bengal, 700001.

When was Pyra Pharmaceutical Limited incorporated?

Pyra Pharmaceutical Limited was incorporated on 23 July 2011.

Who are the current directors of Pyra Pharmaceutical Limited?

The current directors of Pyra Pharmaceutical Limited are

What is the primary industry of Pyra Pharmaceutical Limited?

The primary industry of Pyra Pharmaceutical Limited is Pharma.

Is Pyra Pharmaceutical Limited a listed company?

Pyra Pharmaceutical Limited is unlisted.

What is the capital structure of Pyra Pharmaceutical Limited?

The authorized capital of Pyra Pharmaceutical Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Pyra Pharmaceutical Limited?

The compliance status of Pyra Pharmaceutical Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available